Gilead Sciences Inc
XMUN:GIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences Inc
XMUN:GIS
|
US |
|
N
|
Nuvo Pharmaceuticals Inc
F:23N
|
CA |
|
G
|
Geron Corp
F:GON
|
US |
|
Imperial Brands PLC
LSE:IMB
|
UK |
|
A
|
Air Water Inc
F:0AW
|
JP |
|
Q
|
Quanta Services Inc
F:QAA
|
US |
|
H
|
Helen of Troy Ltd
F:HT2
|
BM |
|
Newmark Group Inc
NASDAQ:NMRK
|
US |
|
Spire Global Inc
NYSE:SPIR
|
US |
|
Ares Capital Corp
NASDAQ:ARCC
|
US |
|
Plug Power Inc
NASDAQ:PLUG
|
US |
|
D
|
D R Horton Inc
F:HO2
|
US |
|
Gurit Holding AG
F:GVM0
|
CH |
|
Aptitude Software Group PLC
F:MH5B
|
UK |
|
MERLIN Properties SOCIMI SA
F:MEQA
|
ES |
|
R
|
Ratchthani Leasing PCL
SET:THANI
|
TH |
Wall St Price Targets
GIS Price Targets Summary
Gilead Sciences Inc
According to Wall Street analysts, the average 1-year price target for GIS is 143.26 EUR with a low forecast of 109.42 EUR and a high forecast of 167.83 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GIS's stock price target?
Price Target
143.26
EUR
According to Wall Street analysts, the average 1-year price target for GIS is 143.26 EUR with a low forecast of 109.42 EUR and a high forecast of 167.83 EUR.
What is the Revenue forecast for Gilead Sciences Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.
What is the Gross Profit forecast for Gilead Sciences Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Gilead Sciences Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 8%.
What is the Pre-Tax Income forecast for Gilead Sciences Inc?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Gilead Sciences Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 9%.
